SFG
MDT icon

SNS Financial Group’s Medtronic MDT Stock Holding History

SNS Financial Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Buy
15,942
+947
+6% +$90.7K 0.12% 73
2025
Q4 		$1.45M Sell
14,995
-24
-0.2% -$2.33K 0.13% 67
2025
Q3 		$1.44M Buy
15,019
+30
+0.2% +$2.76K 0.13% 67
2025
Q2 		$1.32M Sell
14,989
-26
-0.2% -$2.21K 0.13% 70
2025
Q1 		$1.36M Sell
15,015
-272
-2% -$24.3K 0.14% 67
2024
Q4 		$1.23M Sell
15,287
-1,723
-10% -$149K 0.13% 76
2024
Q3 		$1.54M Sell
17,010
-183
-1% -$15.4K 0.15% 64
2024
Q2 		$1.37M Buy
17,193
+28
+0.2% +$2.29K 0.15% 65
2024
Q1 		$1.51M Sell
17,165
-255
-1% -$21.8K 0.17% 65
2023
Q4 		$1.44M Buy
17,420
+4,241
+32% +$323K 0.17% 61
2023
Q3 		$1.04M Sell
13,179
-28
-0.2% -$2.34K 0.14% 75
2023
Q2 		$1.17M Buy
13,207
+18
+0.1% +$1.55K 0.15% 74
2023
Q1 		$1.07M Sell
13,189
-12
-0.1% -$978 0.14% 79
2022
Q4 		$1.04M Sell
13,201
-934
-7% -$75.7K 0.14% 83
2022
Q3 		$1.15M Sell
14,135
-4
-0% -$359 0.17% 78
2022
Q2 		$1.28M Sell
14,139
-316
-2% -$32K 0.17% 76
2022
Q1 		$1.6M Hold
14,455
– – 0.18% 76
2021
Q4 		$1.5M Sell
14,455
-167
-1% -$19.3K 0.16% 83
2021
Q3 		$1.83M Sell
14,622
-181
-1% -$23.4K 0.22% 64
2021
Q2 		$1.84M Buy
14,803
+252
+2% +$31.6K 0.23% 61
2021
Q1 		$1.72M Sell
14,551
-615
-4% -$72.1K 0.23% 62
2020
Q4 		$1.78M Buy
15,166
+1,713
+13% +$189K 0.25% 54
2020
Q3 		$1.4M Buy
13,453
+1,308
+11% +$131K 0.22% 65
2020
Q2 		$1.11M Sell
12,145
-474
-4% -$45.5K 0.2% 71
2020
Q1 		$1.14M Sell
12,619
-514
-4% -$54.7K 0.22% 79
2019
Q4 		$1.49M Buy
13,133
+41
+0.3% +$4.5K 0.26% 62
2019
Q3 		$1.42M Buy
13,092
+419
+3% +$43.7K 0.27% 58
2019
Q2 		$1.23M Buy
12,673
+3,415
+37% +$312K 0.23% 71
2019
Q1 		$844K Sell
9,258
-585
-6% -$52.4K 0.19% 81
2018
Q4 		$895K Buy
9,843
+1,404
+17% +$131K 0.22% 79
2018
Q3 		$830K Buy
8,439
+560
+7% +$51.8K 0.2% 80
2018
Q2 		$674K Buy
7,879
+1,005
+15% +$83.9K 0.18% 80
2018
Q1 		$551K Sell
6,874
-856
-11% -$70.6K 0.15% 84
2017
Q4 		$624K Sell
7,730
-2,574
-25% -$206K 0.15% 89
2017
Q3 		$801K Buy
10,304
+2,451
+31% +$203K 0.21% 81
2017
Q2 		$697K Sell
7,853
-933
-11% -$78.7K 0.19% 91
2017
Q1 		$708K Buy
8,786
+5,059
+136% +$395K 0.18% 88
2016
Q4 		$265K Buy
3,727
+946
+34% +$74.3K 0.08% 137
2016
Q3 		$240K Sell
2,781
-69
-2% -$6.01K 0.07% 119
2016
Q2 		$247K Buy
2,850
+100
+4% +$8.09K 0.06% 110
2016
Q1 		$206K Hold
2,750
– – 0.05% 108
2015
Q4 		$212K Buy
+2,750
New +$207K 0.05% 109
2015
Q3 		– Sell
-2,750
Closed -$204K – 130
2015
Q2 		$204K Hold
2,750
– – 0.06% 115
2015
Q1 		$214K Buy
+2,750
New +$208K 0.08% 105

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SNS Financial Group's MDT Position: Q1 2026 in Review

SNS Financial Group increased its Medtronic (MDT) stake by 6.3% in Q1 2026, buying an estimated $90.7K and bringing the position to 15,942 shares worth $1.39M. The position accounts for 0.12% of the portfolio, ranked #73.

SNS Financial Group first reported a position in MDT in Q1 2015 and has held it in 44 quarters since. The position peaked at $1.84M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • SNS Financial Group held 15,942 shares of Medtronic worth $1.39M as of Q1 2026.
  • SNS Financial Group bought 947 Medtronic shares in Q1 2026, an estimated $90.7K.
  • Medtronic made up 0.12% of SNS Financial Group's portfolio in Q1 2026, its #73 holding.
  • SNS Financial Group first reported a position in Medtronic in Q1 2015 and has held it in 44 quarters since.
  • SNS Financial Group's Medtronic position peaked at $1.84M in Q2 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on SNS Financial Group's 13F filing for Q1 2026, filed 14 Apr 2026.